<DOC>
	<DOCNO>NCT00145236</DOCNO>
	<brief_summary>The purpose study determine nebivolol superior placebo treatment elevate blood pressure Black patient mild moderate hypertension .</brief_summary>
	<brief_title>Dosing Study Effects Nebivolol Blood Pressure Black Patients With Mild Moderate Hypertension</brief_title>
	<detailed_description>This study Phase II , 12-week multicenter , randomize , double-blind , parallel group , placebo-controlled study nebivolol range dos Black patient mild moderate hypertension . Treatment administer daily ( qd ) 12 week . The study consist 2 phase : ( 1 ) screening/washout/single-blind placebo run-in ( 2 ) randomization/treatment . Patients 7 schedule clinic visit study ( 6 clinic visit patient current antihypertensive medication ) .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>Black adult average sit diastolic blood pressure great equal 95 mmHg less equal 109 mmHg baseline . Recent myocardial infarction stroke Contraindication betablocker therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Nebivolol</keyword>
	<keyword>Beta-Blocker</keyword>
</DOC>